Medical Device Tax News:

JCT expands analysis of Obama administration proposal for permanent research credit - July 2011

Helping to alleviate the continued weak economic environment, the R&D tax credit under Section 41 of the Internal Revenue Code remains a critical incentive for US medical device companies to invest significantly in activities in the pursuit of new life-saving and life-enhancing devices.

A recent report by the staff of the Congressional Joint Committee on Taxation recognizes recent favorable court decisions in the research credit area, as well as the opportunity to resolve policy issues associated with the credit by crafting legislation to make it permanent. This analysis represents a key step toward eliminating uncertainty with respect to research spending in the medical device and other industries.

Medical Device Tax News: JCT expands analysis of Obama administration proposal for permanent research credit - July 2011